2006•The LancetRequires access

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study

Prakash Deedwania, Philip J. Barter, Rafael Carmena, Jean‐Charles Fruchart, Scott M. Grundy, Steven Haffner, John J.P. Kastelein, John C. LaRosa, Holly C. Schachner, James Shepherd, David D. Waters

Open publisher page 391 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 391 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Atorvastatin, Metabolic syndrome, Internal medicine, Myocardial infarction, Acute coronary syndrome, Cardiology, Cholesterol